Ascendis Pharma A/S
ASND | NASDAQ
$240.91
+$4.19 (+1.77%)
Sep 21, 2026, 11:07 AM ET · Market open
Institutional Ownership
Net OutflowTotal Institutions
291
Total Ownership
88.71%
Capital Flow
-$1.28B
Shares Change
-9.96M
Ownership Distribution
Institutions (88.71%)
Others (11.29%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
neutralNew Positions
34
Increased Positions
146
Reduced Positions
103
Closed Positions
68
New (34)
Increased (146)
Reduced (103)
Closed (68)
Options Sentiment & Activity
bullishPut/Call Ratio
0.163
Call Flow
1,271,837
Put Flow
207,100
Calls (86%)
Puts (14%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0.19% +2.02% | 0.04% | 119.7K | 28.34M | |
| Tudor Investment Corp ET AL | 0.03% 0.00% | < 0.01% | 16.63K | 3.94M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 16.67% -0.49% | 24.92% +10.94% | 10.28M 0.00% | 2.35B +7.26% | |
| Avoro Capital Advisors LLC | 8.21% -1.44% | 11.39% +8.72% | 5.06M -0.95% | 1.16B +6.24% | |
| Westfield Capital Management Co LP | 7.80% -7.63% | 4.62% +0.28% | 4.81M -7.18% | 1.1B -0.44% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove ASND